Product Description
The Tumor Test Marker series, including models YRA385 to YRA391, represents a significant advancement in diagnostic technology for the detection of various tumor markers. These test kits utilize Chemiluminescent Immunoassay (CLIA) methods, known for their high sensitivity and specificity in cancer biomarker detection. The series spans across multiple parameters such as AFP, CEA, CA125, CA15-3, CA19-9, f-PSA, and t-PSA, providing a comprehensive solution for screening and monitoring patients.
Each model in this series is meticulously designed to meet global standards, equipped with certifications including CE, ISO13485, and FSC. The assays are suitable for use in laboratories worldwide, representing a fusion of precision and reliability. Packaged in convenient specifications of 50T/BOX, 100T/BOX, and 24T/BOX, these kits are built to fit the varied demands of different testing environments.
| Model | YRA385 | YRA386 | YRA387 | YRA388 | YRA389 | YRA390 | YRA391 |
|---|---|---|---|---|---|---|---|
| Tested Parameter | AFP | CEA | CA125 | CA15-3 | CA19-9 | f-PSA | t-PSA |
| Analysis Mode | CLIA | ||||||
| Package Specification | 50T/BOX, 100T/BOX, 24T/BOX | ||||||
| Platform | AP (Alkaline Phosphatase) | ||||||
| Storage | 2-8°C | ||||||
| Calibration | 2/6 Points | ||||||
| Certification | CE, ISO13485, FSC | ||||||
Market Price
In the competitive landscape of tumor marker test kits, the Tumor Test Marker series by Kalstein offers an attractive blend of affordability and advanced technology. The pricing for these kits is designed to be accessible, ranging broadly between $500 and $1500, depending on the quantity and specific model variants. This pricing strategy ensures that laboratories, whether small private clinics or major hospital networks, can integrate top-tier diagnostic tools into their routine operations without the burden of excessive cost.
Frequently Asked Questions
What type of biomarkers does the Tumor Test Marker detect?
The series detects a range of critical tumor markers including AFP, CEA, CA125, CA15-3, CA19-9, f-PSA, and t-PSA.
How is the calibration handled for these tests?
The calibration is conducted using either 2 or 6 points systems to ensure accuracy in results across different testing environments.
What certifications do these products hold?
This product line is certified with CE, ISO13485, and FSC, ensuring compliance with international quality and safety standards.
Advantages and Disadvantages
Among the many advantages, the Tumor Test Marker series stands out for its high sensitivity, rapid processing time, and comprehensive testing across multiple cancer markers. The convenience of varying package sizes and the robustness of CLIA technology make it an invaluable asset for modern laboratories.
However, the reliance on sophisticated CLIA technology necessitates access to compatible laboratory equipment, which may pose a challenge for under-resourced facilities. Additionally, the specificity of tests requires trained personnel to interpret results accurately, potentially increasing operational costs if training is required.
Field Usage
The Tumor Test Marker series is primarily employed in hospital laboratories, oncology centers, and specialized diagnostic labs. Its application is essential in initial cancer screening, monitoring progression, and evaluating treatment efficacy. The CLIA technique ensures high precision, making it a preferred method for clinicians seeking detailed insights into tumor presence and behavior.
In practical scenarios, these tests aid in developing patient treatment plans, assessing risk, and conducting large-scale epidemiological studies. The robustness of these markers allows for their integration into automated systems, thereby improving workflow efficiency and reducing human error in result interpretation.
Recommendations
For optimal use of the Tumor Test Marker series, it is recommended to maintain proper storage conditions between 2-8°C to preserve reagent stability. Regular calibration is vital for consistent performance, and following the manufacturer’s instructions can prevent procedural discrepancies. Training personnel on assay protocols and result interpretation can mitigate operational challenges, ensuring the full potential of these diagnostic tools is realized.
Seize the opportunity to enhance your laboratory’s capabilities by obtaining precise and reliable tumor marker diagnostics. Request a quote or make use of the Kalstein Plus platform for automatic quotations, bringing cutting-edge technology into your lab effortlessly.
If you are looking for a fusion of innovation and quality, you have come to the right place. At Kalstein, we offer you the luxury of exploring our exclusive catalog of laboratory equipment. We manufacture each piece of equipment with a level of excellence. Our intuitive and agile online purchasing channels are designed for your convenience, ensuring the most friendly prices. Hesitate no more, we bring science to life, it is time to become part of our community. https://kalstein.net/en/product/tumor-test-marker-yra385-yra391/.
